Decentralized trials can benefit patients, researchers, and the development of new treatments through improved patient experience, more efficient research processes, and potential cost savings. DTRA's priorities and initiatives focus on advancing decentralized trials and research, which are crucial for enhancing patient access and experience, while reducing barriers to participation in clinical studies. Our goal is to promote decentralized trials by establishing clear goals and recommendations, such as defining common nomenclature, promoting best practices, and facilitating education and information sharing. Through these efforts, we seek to improve decentralized trials and support implementation and adoption, ultimately leading to more inclusive, accessible, and patient-centered clinical studies.
